Literature DB >> 10679309

Identification of viral macrophage inflammatory protein (vMIP)-II as a ligand for GPR5/XCR1.

L Shan1, X Qiao, E Oldham, D Catron, H Kaminski, D Lundell, A Zlotnik, E Gustafson, J A Hedrick.   

Abstract

Lymphotactin is unique among chemokines in that it contains only two of four conserved cysteines and may possess a structure less constrained than other chemokines. The viral chemokine vMIP-II, which presumably has a structure similar to that of CC chemokines has been shown to inhibit many chemokine receptors, but its activity at GPR5/XCR1 has not been described. Interestingly, vMIP-II (but not vMIP-I) was found to be a potent antagonist of lymphotactin activity at GPR5/XCR1, extending the range of chemokine classes that this viral protein is known to inhibit to include the C class chemokine. In addition, we have extended previous analyses of GPR5/XCR1 expression and show that this receptor is expressed in leukocyte cells previously shown to be responsive to lymphotactin. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10679309     DOI: 10.1006/bbrc.2000.2235

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

1.  Human herpesvirus 8-encoded cytokines.

Authors:  John Nicholas
Journal:  Future Virol       Date:  2010-03       Impact factor: 1.831

2.  Structural rearrangement of human lymphotactin, a C chemokine, under physiological solution conditions.

Authors:  E Sonay Kuloğlu; Darrell R McCaslin; John L Markley; Brian F Volkman
Journal:  J Biol Chem       Date:  2002-03-11       Impact factor: 5.157

3.  Structure-function guided modeling of chemokine-GPCR specificity for the chemokine XCL1 and its receptor XCR1.

Authors:  Jamie C Fox; Monica A Thomas; Acacia F Dishman; Olav Larsen; Takashi Nakayama; Osamu Yoshie; Mette Marie Rosenkilde; Brian F Volkman
Journal:  Sci Signal       Date:  2019-09-03       Impact factor: 8.192

4.  Expressions of lymphotactin and its receptor, XCR, in Lewis rats with experimental autoimmune anterior uveitis.

Authors:  Po-Ting Yeh; Feng-An Lin; Chang-Pin Lin; Chung-May Yang; Muh-Shy Chen; Chang-Hao Yang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-06-29       Impact factor: 3.117

5.  An engineered second disulfide bond restricts lymphotactin/XCL1 to a chemokine-like conformation with XCR1 agonist activity.

Authors:  Robbyn L Tuinstra; Francis C Peterson; E Sonay Elgin; Adam J Pelzek; Brian F Volkman
Journal:  Biochemistry       Date:  2007-02-16       Impact factor: 3.162

6.  Structural and agonist properties of XCL2, the other member of the C-chemokine subfamily.

Authors:  Jamie C Fox; Takashi Nakayama; Robert C Tyler; Tara L Sander; Osamu Yoshie; Brian F Volkman
Journal:  Cytokine       Date:  2014-12-11       Impact factor: 3.861

7.  Interconversion between two unrelated protein folds in the lymphotactin native state.

Authors:  Robbyn L Tuinstra; Francis C Peterson; Snjezana Kutlesa; E Sonay Elgin; Michael A Kron; Brian F Volkman
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-25       Impact factor: 11.205

8.  Engineering Metamorphic Chemokine Lymphotactin/XCL1 into the GAG-Binding, HIV-Inhibitory Dimer Conformation.

Authors:  Jamie C Fox; Robert C Tyler; Christina Guzzo; Robbyn L Tuinstra; Francis C Peterson; Paolo Lusso; Brian F Volkman
Journal:  ACS Chem Biol       Date:  2015-09-02       Impact factor: 5.100

9.  Autocrine and paracrine promotion of cell survival and virus replication by human herpesvirus 8 chemokines.

Authors:  Young Bong Choi; John Nicholas
Journal:  J Virol       Date:  2008-04-23       Impact factor: 5.103

10.  Chapter 3. Lymphotactin structural dynamics.

Authors:  Brian F Volkman; Tina Y Liu; Francis C Peterson
Journal:  Methods Enzymol       Date:  2009       Impact factor: 1.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.